Valeria Solari
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Valeria Solari has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
Prem Puri
Children’s Research Centre, Our Lady’s Children’s Hospital and National Children’s Hospital Tallaght, Dublin, Ireland
12 shared publicationsAnna Piaseczna Piotrowska
Children's Research Centre, University College Dublin, Our Lady's Hospital for Sick Children, Dublin, Ireland
9 shared publications- Prem Puri
University College Dublin, Dublin, Ireland
8 shared publications Boris Chertin
Children's Research Centre, Our Lady's Hospital for Sick Children, Crumlin, University College Dublin, Dublin 12, Ireland
4 shared publications- Edwin Alexander Yates
Department of Biochemistry, Cell and Systems Biology, Institute of Molecular and Integrative Biology, University of Liverpool, Liverpool L69 7ZB, UK
4 shared publications Hideki Shima
Our Lady’s Hospital for Sick Children
4 shared publications
Latest Publications
- 12 October 2018
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 107 (4) , 1304-1309
Expanding intestinal segment using osmotic hydrogel: An in vivo study
Intestinal circumferential expansion is essential for bowel lengthening in patients with Short Bowel Syndrome. We hypothesized use of an endoluminal osmotic hydrogel expander (EOHE) as a novel approach for intestinal expansion.An EOHE was introduced into an isolated intestinal segment of New Zealand rabbits, with a similar segment created as a control. After 4weeks, the segments were retrieved for analysis. Weight, inflammatory markers and fluoroscopy data was recorded weekly. EOHE allowed successful expansion of intestinal segments from 4.68 ± 0.35 to 9.79 ± 0.35 cm (p = 0.01). Increase in intestinal length was 167.8 ± 35.21% in segments with EOHE vs. 23.03 ± 4.2% in the control group (p < 0.01). A significant intestinal dilatation (214.4 ± 1.58 vs. 34.59 ± 1.23%, p < 0.01) was demonstrated. Hematoxylin and eosin stain revealed conservation of intestinal architecture with muscle hypertrophy and flattening of the epithelium possibly due to compression. No reduction of rabbit weight, inflammatory markers or liver damage was described. EOHE appears to produce safe intestinal expansion, achieving increased length and dilatation suitable for lengthening procedure. This approach may allow development of similar techniques to expand bowel in short bowel patients. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 107B: 1304–1309, 2019.
- 12 October 2018
- Published by Wiley in Journal of Biomedical Materials Research Part B: Applied Biomaterials
- Vol. 107 (4) , 1304-1309
Expanding intestinal segment using osmotic hydrogel: An in vivo study
Intestinal circumferential expansion is essential for bowel lengthening in patients with Short Bowel Syndrome. We hypothesized use of an endoluminal osmotic hydrogel expander (EOHE) as a novel approach for intestinal expansion.An EOHE was introduced into an isolated intestinal segment of New Zealand rabbits, with a similar segment created as a control. After 4weeks, the segments were retrieved for analysis. Weight, inflammatory markers and fluoroscopy data was recorded weekly. EOHE allowed successful expansion of intestinal segments from 4.68 ± 0.35 to 9.79 ± 0.35 cm (p = 0.01). Increase in intestinal length was 167.8 ± 35.21% in segments with EOHE vs. 23.03 ± 4.2% in the control group (p < 0.01). A significant intestinal dilatation (214.4 ± 1.58 vs. 34.59 ± 1.23%, p < 0.01) was demonstrated. Hematoxylin and eosin stain revealed conservation of intestinal architecture with muscle hypertrophy and flattening of the epithelium possibly due to compression. No reduction of rabbit weight, inflammatory markers or liver damage was described. EOHE appears to produce safe intestinal expansion, achieving increased length and dilatation suitable for lengthening procedure. This approach may allow development of similar techniques to expand bowel in short bowel patients. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 107B: 1304–1309, 2019.
- 28 April 2015
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 13 (21) , 6066-6072
Heparan sulfate phage display antibodies recognise epitopes defined by a combination of sugar sequence and cation binding
Sugar sequence and M+binding defines HS phage display Ab recognition.
- 28 April 2015
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 13 (21) , 6066-6072
Heparan sulfate phage display antibodies recognise epitopes defined by a combination of sugar sequence and cation binding
Sugar sequence and M+binding defines HS phage display Ab recognition.
- 30 October 2014
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 74 (21) , 5999-6009
MYCN-Dependent Expression of Sulfatase-2 Regulates Neuroblastoma Cell Survival
Heparan sulfate proteoglycans (HSPG) play a critical role in the interaction of tumor cells and their microenvironment. HSPG activity is dictated by sulfation patterns controlled by sulfotransferases, which add sulfate groups, and sulfatases (Sulf), which remove 6-O-sulfates. Here, we report altered expression of these enzymes in human neuroblastoma cells with higher levels of Sulf-2 expression, a specific feature of MYCN-amplified cells (MYCN-A cells) that represent a particularly aggressive subclass. Sulf-2 overexpression in neuroblastoma cells lacking MYCN amplification (MYCN-NA cells) increased their in vitro survival. Mechanistic investigations revealed evidence of a link between Sulf-2 expression and MYCN pathogenicity in vitro and in vivo. Analysis of Sulf-2 protein expression in 65 human neuroblastoma tumors demonstrated a higher level of Sulf-2 expression in MYCN-A tumors than in MYCN-NA tumors. In two different patient cohorts, we confirmed the association in expression patterns of Sulf-2 and MYCN and determined that Sulf-2 overexpression predicted poor outcomes in a nonindependent manner with MYCN. Our findings define Sulf-2 as a novel positive regulator of neuroblastoma pathogenicity that contributes to MYCN oncogenicity. Cancer Res; 74(21); 5999–6009. ©2014 AACR.
- 30 October 2014
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 74 (21) , 5999-6009
MYCN-Dependent Expression of Sulfatase-2 Regulates Neuroblastoma Cell Survival
Heparan sulfate proteoglycans (HSPG) play a critical role in the interaction of tumor cells and their microenvironment. HSPG activity is dictated by sulfation patterns controlled by sulfotransferases, which add sulfate groups, and sulfatases (Sulf), which remove 6-O-sulfates. Here, we report altered expression of these enzymes in human neuroblastoma cells with higher levels of Sulf-2 expression, a specific feature of MYCN-amplified cells (MYCN-A cells) that represent a particularly aggressive subclass. Sulf-2 overexpression in neuroblastoma cells lacking MYCN amplification (MYCN-NA cells) increased their in vitro survival. Mechanistic investigations revealed evidence of a link between Sulf-2 expression and MYCN pathogenicity in vitro and in vivo. Analysis of Sulf-2 protein expression in 65 human neuroblastoma tumors demonstrated a higher level of Sulf-2 expression in MYCN-A tumors than in MYCN-NA tumors. In two different patient cohorts, we confirmed the association in expression patterns of Sulf-2 and MYCN and determined that Sulf-2 overexpression predicted poor outcomes in a nonindependent manner with MYCN. Our findings define Sulf-2 as a novel positive regulator of neuroblastoma pathogenicity that contributes to MYCN oncogenicity. Cancer Res; 74(21); 5999–6009. ©2014 AACR.
- Open Access
- 1 May 2012
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 45 (5) , 386-391
Heparan sulphate, its derivatives and analogues share structural characteristics that can be exploited, particularly in inhibiting microbial attachment
Heparan sulphate (HS) and the related polysaccharide, heparin, exhibit conformational and charge arrangement properties, which provide a degree of redundancy allowing several seemingly distinct sequences to exhibit the same activity. This can also be mimicked by other sulphated polysaccharides, both in overall effect and in the details of interactions and structural consequences of interactions with proteins. Together, these provide a source of active compounds suitable for further development as potential drugs. These polysaccharides also possess considerable size, which bestows upon them an additional useful property: the capability of disrupting processes comprising many individual interactions, such as those characterising the attachment of microbial pathogens to host cells. The range of involvement of HS in microbial attachment is reviewed and examples, which include viral, bacterial and parasitic infections and which, in many cases, are now being investigated as potential targets for intervention, are identified.
- 1 May 2012
- Published by FapUNIFESP (SciELO) in Brazilian Journal of Medical and Biological Research
- Vol. 45 (5) , 386-391
Open AccessHeparan sulphate, its derivatives and analogues share structural characteristics that can be exploited, particularly in inhibiting microbial attachment
Heparan sulphate (HS) and the related polysaccharide, heparin, exhibit conformational and charge arrangement properties, which provide a degree of redundancy allowing several seemingly distinct sequences to exhibit the same activity. This can also be mimicked by other sulphated polysaccharides, both in overall effect and in the details of interactions and structural consequences of interactions with proteins. Together, these provide a source of active compounds suitable for further development as potential drugs. These polysaccharides also possess considerable size, which bestows upon them an additional useful property: the capability of disrupting processes comprising many individual interactions, such as those characterising the attachment of microbial pathogens to host cells. The range of involvement of HS in microbial attachment is reviewed and examples, which include viral, bacterial and parasitic infections and which, in many cases, are now being investigated as potential targets for intervention, are identified.
- 1 May 2011
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 46 (5) , e5-e7
Enhancing safety of laparoscopic vascular control for neonatal sacrococcygeal teratoma
- 1 May 2011
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 46 (5) , e5-e7
Enhancing safety of laparoscopic vascular control for neonatal sacrococcygeal teratoma
- 1 March 2011
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 46 (3) , e37-e40
Elective suprarenal and infrarenal cavectomy for excision of giant retroperitoneal teratoma in infancy
- 1 March 2011
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 46 (3) , e37-e40
Elective suprarenal and infrarenal cavectomy for excision of giant retroperitoneal teratoma in infancy
- 1 February 2011
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 46 (2) , e15-e17
Laparoscopic excision of a retroperitoneal lymphatic malformation in a newborn
- 1 February 2011
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 46 (2) , e15-e17
Laparoscopic excision of a retroperitoneal lymphatic malformation in a newborn
- 1 January 2011
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 46 (1) , e13-e19
Excision of extensive metastatic dysgerminoma to control refractory hypercalcaemia in a child at high risk for tumour-lysis syndrome
- 1 January 2011
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 46 (1) , e13-e19
Excision of extensive metastatic dysgerminoma to control refractory hypercalcaemia in a child at high risk for tumour-lysis syndrome
- 1 October 2010
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 45 (10) , e29-e32
Excision of ganglioneuroma from skull base to aortic arch
- 1 October 2010
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 45 (10) , e29-e32
Excision of ganglioneuroma from skull base to aortic arch
- Open Access
- 20 July 2010
- Published by Springer Nature in British Journal of Cancer
- Vol. 103 (4) , 593-594
Determining the anti-coagulant-independent anti-cancer effects of heparin
- 20 July 2010
- Published by Springer Nature in British Journal of Cancer
- Vol. 103 (4) , 593-594
Open AccessDetermining the anti-coagulant-independent anti-cancer effects of heparin